Form 4 holding
Chief Medical Officer
NovaBridge Biosciences
- Security class
- Ordinary Shares
- Shares / value
- 157,941
- Estimated value
- $104,241
- Report date
- 18 Jun 2026
- Price
- $0.6600
- Ownership
- Direct
Phillip Andrew Dennis
Insider Reports History
- Reporting-owner location
- Rockville, MD
- Latest reporting-owner signature
-
/s/ Xi-Yong (Sean) Fu as attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Phillip Andrew Dennis
Form 4 holding
Chief Medical Officer
NovaBridge Biosciences
- Security class
- Restricted Share Units
- Shares / value
- 82,422
- Estimated value
- Report date
- 17 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Insider Reports Filed by Phillip Andrew Dennis
4
NBP
NovaBridge Biosciences
- Report period
- 17 Jun 2026
- Transactions
- 3
- Transaction value
- -$5,606
- Accepted by SEC
- 22 Jun 2026, 17:23
- Role
- Chief Medical Officer
- Next action
- Open filing details
3
NBP
NovaBridge Biosciences
- Report period
- 18 Mar 2026
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 19 Mar 2026, 06:18
- Role
- Chief Medical Officer
- Next action
- Open filing details